MarketInOut Stock Screener Log In | Sign Up

Alivus Life Sciences Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Alivus Life Sciences Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization171,604 mln
Float30.88 mln

EPS

49.03
Exceptional

P / E

28.71
Elevated

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.36
Borderline

Relative Strength

90 / 100
Top performer

Debt / Equity

0.02
Debt-free

Business Description

Alivus Life Sciences Limited, formerly Glenmark Life Sciences and now a subsidiary of Nirma Limited, is a Mumbai-based company founded in 2001 that produces and sells active pharmaceutical ingredients across markets in India, Japan, Europe, and the Americas. The company supplies ingredients used in treatments for a wide range of health conditions, including heart disease, diabetes, cancer, and neurological disorders. It also manufactures pharmaceutical products on behalf of large multinational companies and specialty firms under contract arrangements.

Key Fundamentals

EPS49.03
P/E28.71
ROE19.74
RPS211
ROIC21.72
ROA16.37
Interest Cover140
EBITDA, mln8,849
EV / EBITDA18.64
EV / EBIT20.47
Revenue, mln25,904
EV / Revenue6.37

Quote Details

Last 1,407.80
Change 12.7 (0.91%)
Open 1,437.20
Volume 324,226
Turnover 456,445,376
Average Volume 21,073

Financial Ratios

Pre-Tax Profit Margin31
Leverage Ratio1.20
Current Ratio5.22
Price / Book5.16
Price / Tangible Book5.21
Price / Cash Flow65.78
Price / Free Cash Flow66.47
Debt / Equity0.02
Price / Sales6.65
PEG Ratio7.30

Financial Strength

Altman Z-Score18.31
Piotroski F-Score 6 / 9
Beneish M-Score-2.36
Price to Intrinsic Value3.14
Price to Graham Number2.62

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 13.03% 95 / 100   
1 Month 3.45% 86 / 100   
2 Months 27.96% 92 / 100   
6 Months 40.58% 91 / 100   
1 Year 53.43% 92 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog